| 1 |
A review on multivesicular liposomes for pharmaceutical applications: preparation, characterization, and translational challenges
Akash Chaurasiya, Amruta Gorajiya, Kanan Panchal et al. · Drug Delivery and Translational Research
|
Oct 2021 |
62 |
| 2 |
Development and Evaluation of Ethyl Cellulose-Based Transdermal Films of Furosemide for Improved In Vitro Skin Permeation
Dhaval P. Patel, C. Mallikarjuna Setty, Gaurav Navinbhai Mistry et al. · AAPS PharmSciTech
Open access |
20 Apr 2009 |
54 |
| 3 |
4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents
Arif B. Siddiqui, Amit R. Trivedi, Vipul B. Kataria et al. · Bioorganic & Medicinal Chemistry Letters
|
14 Feb 2014 |
48 |
| 4 |
Mechanistic Insights of Formulation Approaches for the Treatment of Nail Infection: Conventional and Novel Drug Delivery Approaches
Vikas Agrawal, Rashmin B. Patel, Patel Mrunali et al. · AAPS PharmSciTech
|
14 Jan 2020 |
39 |
| 5 |
Design and evaluation of microemulsion-based efinaconazole formulations for targeted treatment of onychomycosis through transungual route: Ex vivo and nail clipping studies
Vikas Agrawal, Rashmin B. Patel, Mrunali Rashmin Patel et al. · Colloids and Surfaces B Biointerfaces
|
21 Feb 2021 |
37 |
| 6 |
RP-HPLC method for quantitative estimation of Efinaconazole in topical microemulsion and microemulsion-based-gel formulations and in presence of its degradation products
Vikas Agrawal, Rashmin B. Patel, Patel Mrunali et al. · Microchemical Journal
|
24 Feb 2020 |
30 |
| 7 |
Mechanochemical synthesis of brexpiprazole cocrystals to improve its pharmaceutical attributes
Mohsin R. Arabiani, Anurag Lodagekar, Balvant Yadav et al. · CrystEngComm
|
2019 |
23 |
| 8 |
Brexpiprazole–catechol cocrystal: structure elucidation, excipient compatibility and stability
Mohsin R. Arabiani, Bal Raju K, Surojit Bhunia et al. · CrystEngComm
|
2019 |
21 |
| 9 |
Quantitative X-ray fluorescence analysis: Trace level detection of toxic elemental impurities in drug product by ED-XRF spectrometer
Anirban Roy Chowdhury, Neelesh Maheshwari, Jigar Y. Soni et al. · Journal of Pharmaceutical and Biomedical Analysis
|
23 Jun 2020 |
20 |
| 10 |
Efinaconazole: DoE-supported development and validation of a quantitative HPTLC method and its application for the assay of drugs in solution and microemulsion-based formulations
Rashmin B. Patel, Mrunali Rashmin Patel, Nikesh R. Patni et al. · Analytical Methods
|
2020 |
19 |
| 11 |
Delivery Strategies and Clinical Significance of Oral Colon-targeted Drug Delivery Systems
Kailash Bansal, Amit Mukharya, Anil B. Jindal · AAPS PharmSciTech
|
31 Jan 2026 |
6 |
| 12 |
A Phase 3 Trial of IPX203 vs CD-LD IR in Parkinson’s Disease Patients with Motor Fluctuations (RISE-PD) (S16.010)
Robert A. Hauser, Alberto J. Espay, Peter A. LeWitt et al. · Neurology
|
3 May 2022 |
6 |
| 13 |
Green UHPLC approach for the quantitative determination of tiopronin residues in cleaning validation processes
Jagdish Gohel, Ajay I. Patel, Rajendra Kotadiya · BMC Chemistry
Open access |
24 Oct 2025 |
5 |
| 14 |
Stability testing parameters of nanoscaled product development
Akash Chaurasiya, Amruta Gorajiya, Jayabalan Nirmal · Elsevier eBooks
Book chapter |
2022 |
4 |
| 15 |
Regulatory Procedure of Post Approval Changes and Comparative Requirements of EU and USA Regulatory Regions
Trivedi Ankit, Deshpande Shrikalp, Zaveri Maitreyi et al. · Journal of Pharmaceutical Research International
Open access |
21 Oct 2021 |
4 |
| 16 |
Characterization of Prednisone Degradants via Forced Degradation Studies: A UHPLC‐Based Approach With HRMS/MS, NMR, and Toxicity Predictions Using Quantitative Structure–Activity Relationship Models
Ajay Patel, Anirban Roy Chowdhury, Sanjay Mevada et al. · Separation Science Plus
Open access |
Jun 2025 |
3 |
| 17 |
Lowering LDL cholesterol by PCSK9 inhibition: a new era of gene silencing, RNA, and alternative therapies
Mitali Paryani, Nikita Gupta, Sanjay Kumar Jain et al. · Naunyn-Schmiedeberg s Archives of Pharmacology
|
30 Jan 2025 |
3 |
| 18 |
An Insight Into Risk Assessment and Reformulation of Drug Products Manufactured Using Benzene Grade Carbomer: A Regulatory Perspective
Kailash Bansal, Anil B. Jindal · AAPS PharmSciTech
|
15 Jul 2024 |
3 |
| 19 |
Analytical validation of a microwave-assisted ICP-MS method for the quantification of elemental impurities in doxycycline hyclate tablets
Tirth V. Shah, Sneha R. Sagar, Sujal Shah et al. · Chemical Papers
|
18 Mar 2024 |
3 |
| 20 |
Base‐Promoted Isomerization of cis ‐Lactam to trans ‐Lactam of Asenapine and Optimization of Crystallization Process of Asenapine Maleate Salt: An Antipsychotic Drug
Krishna Vinigiri, Bal Raju Kammari, Narasimha Rao P et al. · ChemistrySelect
|
24 Jun 2019 |
3 |
| 21 |
A Comprehensive Review of Analytical Methods on Everolimus: A Basis for Cleaning Residue Quantitation
Jagdish Gohel, Rajendra Kotadiya · Separation Science Plus
|
16 Dec 2024 |
2 |
| 22 |
DEVELOPMENT OF NOVEL SINGLE HPLC METHOD FOR SIMULTANEOUS SEPARATION OF MULTIPLE IMPURITIES IN DEXAMETHASONE DRUG PRODUCT
JIGESH H. SHAH, Tushar Mehta, Amit Mukharya et al. · International Journal of Pharmacy and Pharmaceutical Sciences
Open access |
Nov 2024 |
2 |
| 23 |
Formulation and characterization of dexmedetomidine HCL liposomes in gel for intraarticular administration
Amruta Gorajiya, Pragna Shelat, Anita Lalwani · International Journal of Health Sciences
Open access |
28 Apr 2022 |
2 |
| 24 |
Transition of Pharmaceutical Regulations: The New Regulatory Era after Brexit
Trivedi Ankit, Deshpande Shrikalp, Zaveri Maitreyi et al. · Journal of Pharmaceutical Research International
Open access |
29 Oct 2021 |
2 |
| 25 |
Efficacy of L-Cysteine as an Anti-Oxidant in Papain Catalyzed Synthesis of Oligopeptides in Organic Solvent System
Santhana Srinivasan, Shubhen Kapila, Daniel Forciniti et al. · Biochemistry & Analytical Biochemistry
|
2017 |
2 |
| 26 |
Targeting Mpox virus proteins with tea phytochemicals: A computational study
Sumit Arora, Pranjali Kapgate, Avanti Girdekar et al. · Pharmacological Research - Natural Products
|
12 Aug 2025 |
1 |
| 27 |
Duration of Benefit Per Dose: Post Hoc Analysis of “Good On” Time Per Dose for IPX203 vs CD-LD IR in the RISE-PD Phase 3 Trial (P10-11.002)
Robert A. Hauser, Hubert H. Fernandez, Kevin J. Klos et al. · Neurology
|
3 May 2022 |
1 |
| 28 |
Mixing
Kailash Bansal, Anil B. Jindal · AAPS introductions in the pharmaceutical sciences
Book chapter |
2023 |
1 |
| 29 |
Long-term Safety and Efficacy of IPX203 in Parkinson’s Disease Patients with Motor Fluctuations: A 9-Month Open-label Extension Trial (S32.006)
Alberto J. Espay, Robert Hauser, Rohit Dhall et al. · Neurology
|
25 Apr 2023 |
1 |
| 30 |
The Amalgamation of Risk Assessment Using Quality by Design Principles and Prediction of Regression Models in the Development of Dexmedetomidine-loaded Lipospheres for Intra-articular Administration
Amruta Gorajiya, Anita Lalwani · Journal of Young Pharmacists
Open access |
17 Apr 2023 |
1 |
| 31 |
Improving pharmacokinetics and pharmacodynamics of berberine hydrochloride using solid dispersion: A therapeutic approach to hyperlipidemia
Mitali Paryani, Nikita Gupta, Krishna Bhalodi et al. · Drying Technology
|
12 Sep 2026 |
0 |
| 32 |
Stability-indicating RP-LC method for simultaneous estimation of dapagliflozin propanediol monohydrate and telmisartan based on QbD approach
K K PATEL, Usmangani K. Chhalotiya, Dimal A. Shah et al. · Discover Pharmaceutical Sciences
Open access |
12 Jun 2026 |
0 |
| 33 |
Effect of CREXONT® (IPX203, ER CD-LD) on Sleep in Patients with Parkinson’s Disease and Associated Sleep Disturbances (P3-17.015)
Okeanis Vaou, Simon Allard, Alan G. Morris et al. · Neurology
|
9 Jun 2026 |
0 |
| 34 |
CREXONT® (IPX203, ER CD-LD) Super-responders: Enhanced Symptom Control in Parkinson’s Disease (P3-17.003)
Simon Allard, Ghazal Banisadr, Stanley Fisher et al. · Neurology
|
9 Jun 2026 |
0 |
| 35 |
Simplified Twice-daily CREXONT® Regimen Delivers Significant Gain in “Good On” Time in Parkinson’s Patients with Lower Levodopa Needs (P3-17.004)
Simon Allard, Stanley Fisher, Laxman Bahroo · Neurology
|
9 Jun 2026 |
0 |
| 36 |
Effect of Opicapone on Sleep-related Complaints and Non-motor Burden in Parkinson’s Patients: A Post-hoc Analysis of the OASIS Trial (P3-17.012)
Miguel Gago, Raquel Almeida Costa, Helena Brigas et al. · Neurology
|
9 Jun 2026 |
0 |
| 37 |
Low Risk of Motor Complications in Early Parkinson’s Disease Patients Treated with Opicapone in the EPSILON Study: Effect of Levodopa Dose (P3-17.010)
J T Ferreira, Olivier Rascol, Fabrizio Stocchi et al. · Neurology
|
9 Jun 2026 |
0 |
| 38 |
Switching to CREXONT® Improves “Good On” Time and Reduces Motor Fluctuations in Parkinson’s Disease: Interim Results from the Real-world ELEVATE-PD Phase Four Study (P3-17.001)
Stuart Isaacson, Joohi Jimenez Shahed, Michael Soileau et al. · Neurology
|
9 Jun 2026 |
0 |
| 39 |
Comparative Efficacy of Opicapone and Entacapone in the Management of Motor Fluctuations in Parkinson’s Disease (P3-17.002)
Stuart Isaacson, Fahd Amjad, Sandeep Thakkar et al. · Neurology
|
9 Jun 2026 |
0 |
| 40 |
Structural Identification of Novel Degradation Impurities in Teriflunomide Drug Product Using NMR, IR, Mass Spectrometry, and Quantification by RP‐HPLC
Jigesh V. Shah, Tushar Mehta, A. Chaudhary et al. · Separation Science Plus
|
Nov 2025 |
0 |
| 41 |
Comparative Assessment of Levodopa and Carbidopa Cleanability from Stainless Steel Surfaces: A Risk-Based Approach for Pharmaceutical Cleaning Validation
Birju Patel, Jayminkumar Patel · SSRN Electronic Journal
PreprintOpen access |
2025 |
0 |
| 42 |
In-silico and In-vivo Investigations Reveal Ameliorative Potential of Myricetin Against Doxorubicin-induced Myocardial Damage via Modulation of NF-κB Signaling Pathway
Purvaj G. Barote, Harshal D. Pawar, M.I. Sayyed et al. · Current Protein and Peptide Science
|
6 Oct 2025 |
0 |
| 43 |
Novel Liquid Chromatography Method with Core Shell Technology Column for Quantification of Lurasidone Hydrochloride in Pharmaceutical Product
Dadheech Pankaj, Anju Goyal · International Journal of Zoological Investigations
Open access |
2025 |
0 |
| 44 |
Stability-Indicating UPLC Method for the Estimation of Fenofibrate (Micronized) Capsules
Jain Jitendra Kumar, Mehta Preeti, Dadheech Pankaj · International Journal of Zoological Investigations
Open access |
Jun 2025 |
0 |
| 45 |
Development and Validation of Novel UPLC Method for Identification of Other Product in Aripiprazole
Dadheech Pankaj, Anju Goyal · International Journal of Zoological Investigations
Open access |
Jun 2025 |
0 |
| 46 |
Advanced characterization of frovatriptan degradation products using 2D NMR and LC-HRMS/MS: Integrative stability and forced degradation analysis to uncover novel impurities
Ajay Patel, Anirban Roy Chowdhury, Sanjay Mevada et al. · Microchemical Journal
|
8 Apr 2025 |
0 |
| 47 |
Long-term Follow-up of Opicapone Use as Add-on to Levodopa in Parkinson’s Patients Without Motor Fluctuations: Findings from the EPSILON Study (P7-5.027)
Joaquim Ferreira, Olivier Rascol, Fabrizio Stocchi et al. · Neurology
|
7 Apr 2025 |
0 |
| 48 |
Opicapone as First-line Strategy for the Treatment of Wearing-off in Patients with Parkinson’s Disease (P7-5.026)
Joaquim José Ferreira, Jee‐Young Lee, Hyeo‐Il Ma et al. · Neurology
|
7 Apr 2025 |
0 |
| 49 |
Opicapone Improved Parkinson’s Disease-related Sleep Disturbances: Findings from the OASIS Study (P11-5.020)
Miguel Fernandes Gago, Raquel Costa, Miguel Fonseca et al. · Neurology
|
7 Apr 2025 |
0 |
| 50 |
Impact of Concomitant Therapy with a Dopamine Agonist on Converting Parkinson’s Disease Patients from Immediate-release Carbidopa-levodopa to CREXONT® (P7-5.024)
Rajesh Pahwa, Neepa Patel, Ramsey A. Falconer et al. · Neurology
|
7 Apr 2025 |
0 |